These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28095913)

  • 1. Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia.
    Hals PA; Wang X; Xiao YF
    Lipids Health Dis; 2017 Jan; 16(1):11. PubMed ID: 28095913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil.
    Hals PA; Wang X; Piscitelli F; Di Marzo V; Xiao YF
    Lipids Health Dis; 2017 Jan; 16(1):16. PubMed ID: 28107816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
    Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
    Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia.
    Bunea R; El Farrah K; Deutsch L
    Altern Med Rev; 2004 Dec; 9(4):420-8. PubMed ID: 15656713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study.
    Berge RK; Ramsvik MS; Bohov P; Svardal A; Nordrehaug JE; Rostrup E; Bruheim I; Bjørndal B
    Lipids Health Dis; 2015 Dec; 14():163. PubMed ID: 26666303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.
    Mozaffarian D; Maki KC; Bays HE; Aguilera F; Gould G; Hegele RA; Moriarty PM; Robinson JG; Shi P; Tur JF; Lapointe JF; Aziz S; Lemieux P;
    JAMA Netw Open; 2022 Jan; 5(1):e2141898. PubMed ID: 34989797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krill Oil Supplementation Improves Dyslipidemia and Lowers Body Weight in Mice Fed a High-Fat Diet Through Activation of AMP-Activated Protein Kinase.
    Yang G; Lee J; Lee S; Kwak D; Choe W; Kang I; Kim SS; Ha J
    J Med Food; 2016 Dec; 19(12):1120-1129. PubMed ID: 27982752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of tissue deposition of omega-3 fatty acids from polar-lipid rich oil of the microalgae Nannochloropsis oculata with krill oil in rats.
    Kagan ML; Levy A; Leikin-Frenkel A
    Food Funct; 2015 Jan; 6(1):186-92. PubMed ID: 25360534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary fatty acids and lipoprotein metabolism: new insights and updates.
    Ooi EM; Ng TW; Watts GF; Barrett PH
    Curr Opin Lipidol; 2013 Jun; 24(3):192-7. PubMed ID: 23619368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omega-3 and omega-6 fatty acid-rich oils on the cardiovascular system of thermally injured rabbits: changes in plasma triglycerides, plasma cholesterol, relative blood viscosity, platelet count, and bleeding time.
    Kirmani ZA; Baxter CR; Gorman MA; Ashby J; Ireton-Jones C; Liepa GU
    J Burn Care Rehabil; 1995; 16(3 Pt 1):306-15. PubMed ID: 7673312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
    Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
    J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat.
    Morgado N; Rigotti A; Valenzuela A
    Ann Nutr Metab; 2005; 49(6):397-406. PubMed ID: 16227687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure.
    Sarkkinen ES; Savolainen MJ; Taurio J; Marvola T; Bruheim I
    Lipids Health Dis; 2018 Dec; 17(1):287. PubMed ID: 30572894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary omega-3 fatty acids and cholesterol modify desaturase activities and fatty acyl constituents of rat intestinal brush border and microsomal membranes of diabetic rats.
    Keelan M; Thomson AB; Garg ML; Wierzbicki E; Wierzbicki AA; Clandinin MT
    Diabetes Res; 1994; 26(2):47-66. PubMed ID: 7554726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of omega-3 fatty acids on risk factors for cardiovascular diseases].
    Yam D; Bott-Kanner G; Genin I; Shinitzky M; Klainman E
    Harefuah; 2001 Dec; 140(12):1156-8, 1230. PubMed ID: 11789299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia.
    Pirillo A; Catapano AL
    Atheroscler Suppl; 2013 Aug; 14(2):237-42. PubMed ID: 23958479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol.
    Savinova OV; Fillaus K; Harris WS; Shearer GC
    Atherosclerosis; 2015 Jun; 240(2):520-5. PubMed ID: 25932792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.